Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
2015
Acute myeloid leukemia (AML) can develop after an antecedent myeloid malignancy (secondary AML [s-AML]), after leukemogenic therapy (therapy-related AML [t-AML]), or without an identifiable prodrome or known exposure (de novo AML). The genetic basis of these distinct pathways of AML development has
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
33
References
459
Citations
NaN
KQI